Your browser doesn't support javascript.
loading
The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas.
Pertel, P E; Eisenstein, B I; Link, A S; Donfrid, B; Biermann, E J A; Bernardo, P; Martone, W J.
Affiliation
  • Pertel PE; Clinical Research, Cubist Pharmaceuticals, Lexington, MA 02421, USA. peter.pertel@cubist.com
Int J Clin Pract ; 63(3): 368-75, 2009 Mar.
Article in En | MEDLINE | ID: mdl-19222623
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vancomycin / Cellulitis / Daptomycin / Erysipelas / Anti-Bacterial Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pract Journal subject: MEDICINA Year: 2009 Document type: Article Affiliation country: Estados Unidos Country of publication: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vancomycin / Cellulitis / Daptomycin / Erysipelas / Anti-Bacterial Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pract Journal subject: MEDICINA Year: 2009 Document type: Article Affiliation country: Estados Unidos Country of publication: India